Skip to content

What is the most common cause of drug-induced liver injury?

5 min read

According to sources like UC San Diego Health and the NIH, acetaminophen overdose is the most common cause of drug-induced liver injury (DILI) leading to acute liver failure in the United States. This is due to its widespread availability and the risk of both intentional and unintentional overconsumption, which can have devastating effects on the liver.

Quick Summary

Acetaminophen overdose is the leading cause of severe drug-induced liver injury and acute liver failure, often resulting from exceeding recommended dosages intentionally or accidentally. The liver's detoxification process becomes overwhelmed, producing a toxic metabolite that damages cells. Other medications, particularly certain antibiotics, are frequent causes of unpredictable idiosyncratic liver injuries. Recognition of symptoms and prompt medical intervention are critical for managing DILI.

Key Points

  • Acetaminophen Overdose: The most common cause of acute liver failure related to drug-induced liver injury is an overdose of acetaminophen.

  • Predictable Toxicity: Acetaminophen-induced liver damage is an 'intrinsic' reaction, meaning it is predictable and dose-dependent.

  • Mechanism of Damage: Overdose overwhelms the liver's detoxification process, depleting the antioxidant glutathione and allowing a toxic metabolite (NAPQI) to cause severe oxidative stress and cell death.

  • Idiosyncratic Reactions: For unpredictable DILI, often involving allergic-type reactions, antibiotics like amoxicillin-clavulanate are the most common culprits.

  • Crucial Treatment: The primary treatment for any DILI is prompt cessation of the offending agent, while acetaminophen overdose has a specific antidote, N-acetylcysteine (NAC).

  • High-Risk Factors: Chronic alcohol use, malnutrition, and concurrent use of certain medications or supplements can increase the risk of hepatotoxicity.

  • Diagnosis of Exclusion: DILI diagnosis is often complex, requiring the exclusion of other liver diseases through a thorough medical history, blood tests, and imaging.

In This Article

Acetaminophen: The Leading Cause of Drug-Induced Liver Injury (DILI)

Drug-induced liver injury (DILI) can be caused by a wide range of substances, including prescription drugs, over-the-counter medications, herbal remedies, and dietary supplements. However, the most common cause of severe DILI leading to acute liver failure is an overdose of acetaminophen (paracetamol). This is a significant public health concern, as acetaminophen is widely available in many products for pain and fever relief, increasing the potential for accidental or intentional overconsumption.

The Mechanism of Acetaminophen Hepatotoxicity

Acetaminophen toxicity is dose-dependent, meaning the risk of liver damage increases significantly at higher doses. At therapeutic doses, the liver efficiently metabolizes acetaminophen into nontoxic compounds that are excreted. A small fraction is metabolized by cytochrome P450 (CYP) enzymes into a toxic intermediate called N-acetyl-p-benzoquinone imine (NAPQI). The liver uses a protective antioxidant called glutathione (GSH) to detoxify this NAPQI.

In an overdose situation, the standard metabolic pathways become saturated, leading to an increased production of NAPQI. The liver's stores of glutathione are rapidly depleted, allowing the excess NAPQI to bind to cellular proteins and lipids within liver cells. This covalent binding initiates a cascade of events, including mitochondrial oxidative stress, mitochondrial dysfunction, and ultimately leading to necrotic cell death. This is particularly damaging to the cells in the centrilobular region of the liver.

Key Risk Factors for Acetaminophen Toxicity

Several factors can increase an individual's susceptibility to acetaminophen-induced liver damage, even at doses that might not cause harm in others. These include:

  • Chronic Alcohol Use: Chronic alcohol consumption can deplete glutathione stores and induce CYP2E1 enzymes, which increases NAPQI production. While acute alcohol intake might not have the same effect, chronic, heavy drinkers are at a much higher risk, especially with repeated supratherapeutic doses.
  • Malnutrition or Fasting: Individuals who are malnourished or have been fasting have lower glutathione reserves, reducing the liver's ability to detoxify NAPQI. This is particularly relevant for critically ill patients or those with alcohol use disorder.
  • Concurrent Medications and Supplements: Some drugs, such as certain anti-seizure medications and herbal supplements like St. John's wort, can induce the CYP450 enzyme system, thereby increasing the production of NAPQI.
  • Pre-existing Liver Disease: Patients with underlying liver conditions like cirrhosis or chronic hepatitis C have a diminished ability to metabolize and detoxify drugs, making them more vulnerable to liver injury.
  • Age: Elderly individuals and, conversely, children (if given repeated supratherapeutic doses) may have an increased risk due to differences in metabolism and glutathione regeneration.

Idiosyncratic DILI: The Role of Antibiotics

While acetaminophen is the primary cause of acute liver failure from DILI, most cases of idiosyncratic DILI are attributed to other medications, with antibiotics being the most frequently implicated class. Idiosyncratic DILI is an unpredictable, non-dose-dependent reaction that only occurs in a small percentage of susceptible individuals.

Commonly implicated antibiotics include:

  • Amoxicillin-clavulanate (Augmentin)
  • Isoniazid (for tuberculosis)
  • Sulfonamides (e.g., trimethoprim-sulfamethoxazole)
  • Nitrofurantoin
  • Fluoroquinolones
  • Macrolides (e.g., erythromycin)

The Diagnosis and Management of DILI

Diagnosing DILI requires a high index of suspicion, as it often mimics other liver diseases and is a diagnosis of exclusion. The initial evaluation involves a comprehensive medical history, including all medications and supplements taken, and a physical exam.

Diagnostic Tools include:

  • Blood tests for liver enzymes (ALT, AST, ALP), bilirubin, and coagulation studies (INR).
  • Imaging studies (ultrasound, CT, MRI) to rule out other causes of liver injury.
  • Liver biopsy in some cases to confirm the diagnosis and assess the extent of damage.

The cornerstone of management is prompt action:

  • Stop the Offending Agent: The primary treatment is to immediately discontinue the drug believed to be causing the injury.
  • Specific Antidote: For acetaminophen overdose, N-acetylcysteine (NAC) is the antidote, and its effectiveness is greatest when administered within eight hours of ingestion.
  • Supportive Care: In cases of severe DILI, supportive care in a hospital setting is crucial to manage complications like acute liver failure.
  • Liver Transplantation: For patients with fulminant liver failure, liver transplantation may be the only life-saving option.

Comparing Intrinsic (Acetaminophen) and Idiosyncratic (Antibiotic) DILI

Feature Intrinsic DILI (e.g., Acetaminophen) Idiosyncratic DILI (e.g., Amoxicillin-Clavulanate)
Mechanism Predictable, dose-dependent hepatotoxicity. Unpredictable, non-dose-dependent reaction.
Incidence High, especially with overdose. Rare, affecting a small percentage of users.
Latency Period Short (hours to days post-overdose). Variable (days to weeks, sometimes longer).
Risk Factors Dose, alcohol use, malnutrition, enzyme inducers. Genetic predisposition, age, female sex (for some drugs).
Primary Pathology Centrilobular necrosis due to toxic metabolite NAPQI. Can be hepatocellular, cholestatic, or mixed.
Symptoms Nausea, vomiting, abdominal pain, jaundice (later). Fever, rash, eosinophilia (allergic features) possible.
Treatment Specific antidote (N-acetylcysteine) exists. No specific antidote; stop the drug.

Conclusion

The fact that acetaminophen overdose is the single most common cause of severe drug-induced liver injury underscores the importance of public health awareness regarding safe dosing. While idiosyncratic reactions to other drugs like antibiotics are important to identify, the predictable and dose-dependent nature of acetaminophen's toxicity presents a preventable and treatable threat with proper knowledge and prompt intervention. Patients and healthcare providers must work together to ensure that medications are used responsibly and that any signs of liver injury are immediately investigated. For up-to-date information on specific drugs, the NIH-maintained LiverTox website is an authoritative resource for clinicians and patients.

Understanding the Most Common Causes of Liver Damage from Medications

Can herbal supplements cause drug-induced liver injury?

Yes, herbal and dietary supplements are an increasingly recognized cause of DILI and can lead to serious liver injury. Due to a lack of regulatory oversight and inconsistent ingredients, assessing their hepatotoxic potential can be very challenging.

What are the main differences between intrinsic and idiosyncratic DILI?

Intrinsic DILI is predictable and dose-dependent, meaning it will cause liver injury if enough is ingested (e.g., acetaminophen overdose). Idiosyncratic DILI is unpredictable, not dose-dependent, and occurs rarely in susceptible individuals (e.g., allergic reactions to certain antibiotics).

How does alcohol affect the risk of acetaminophen toxicity?

Chronic alcohol use increases the risk of acetaminophen toxicity by inducing certain liver enzymes and depleting glutathione stores. Patients with a history of heavy alcohol use are more vulnerable to liver damage from repeated supratherapeutic doses of acetaminophen.

Is it always necessary to stop a medication if liver enzymes are slightly elevated?

Not always. Small, transient elevations in liver enzymes can occur with some medications (e.g., statins, antituberculosis drugs) and may resolve on their own. However, specific biochemical criteria are used to determine if discontinuation is necessary, and a healthcare provider should always evaluate the situation.

What is the antidote for acetaminophen overdose?

The specific antidote for acetaminophen overdose is N-acetylcysteine (NAC). It works by restoring glutathione levels in the liver, helping to detoxify the toxic metabolite NAPQI. Its effectiveness is greatest when given early after ingestion.

How is idiosyncratic DILI managed, since there is no specific antidote?

For idiosyncratic DILI, the primary management involves identifying and immediately discontinuing the offending medication. Supportive care is provided to manage symptoms, and in some cases, corticosteroids may be used for immune-mediated reactions.

What is the prognosis for drug-induced liver injury?

Most cases of DILI resolve completely once the causative drug is stopped. However, severe cases can progress to acute liver failure, which has a high mortality rate and may require a liver transplant. Prognosis depends on the severity of the injury, the timing of intervention, and the individual's overall health.

Frequently Asked Questions

The most common cause of severe drug-induced liver injury, especially cases leading to acute liver failure in Western countries, is an overdose of acetaminophen (paracetamol).

The specific antidote for acetaminophen overdose is N-acetylcysteine (NAC), which works by replenishing the liver's glutathione stores to detoxify the toxic metabolite NAPQI. It is most effective when administered early.

Antibiotics are the most frequently implicated drug class in causing idiosyncratic DILI, which is an unpredictable reaction affecting a small percentage of individuals.

Yes, herbal and dietary supplements are an increasingly recognized cause of DILI and can be hepatotoxic. Lack of regulation and inconsistent ingredients make it difficult to predict and assess their risk.

Chronic alcohol use increases the risk of acetaminophen toxicity by depleting the liver's glutathione and inducing the enzymes that produce the toxic metabolite NAPQI. This makes patients with alcohol use disorder more susceptible to harm, especially from repeated high doses.

DILI is primarily a diagnosis of exclusion. It is confirmed by taking a detailed medical history and performing blood tests to check liver function. Imaging or biopsy may be used, and causality is often assessed using standardized methods like RUCAM.

The first and most effective step in managing DILI is to promptly identify and discontinue the offending medication. For acetaminophen overdose, this is followed by administering the specific antidote, N-acetylcysteine.

Risk factors for DILI include the specific drug and its dosage, individual genetics, age, sex, malnutrition or fasting, chronic alcohol use, and underlying liver conditions like hepatitis or cirrhosis.

If DILI is not treated promptly, it can lead to more severe outcomes, including acute liver failure, cirrhosis, the need for liver transplantation, or even death.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.